Alexza Pharmaceuticals, Inc. (ALXA)
$2.24
-0.04 (-1.67%)
| CAPS Rating |
|
|---|---|
| Open | $2.27 |
| Previous Close | $2.28 |
| Daily Range | $2.23 - $2.28 |
| 52-Week Range | $1.16 - $3.53 |
| Market Cap | $74.55M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 75,525 |
| Average Daily Volume | 95,000 |
ALXA
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ALXA Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ALXA News and Commentary
- UPDATE 1-Alexza migraine drug fails to meet goal in study – Reuters
- short and sweet.... here comes the PHARMA-BOOM – Blog at The Motley Fool
- BluePhoenix Solutions & LKQ Corp - Wow Pointz – Blog at The Motley Fool
- All time low for Alexza Pharma... I'M HAVING A PANIC ATTACK – Blog at The Motley Fool
- I'm back....HELP! – Blog at The Motley Fool
Related News and Articles
- The Side Effect of Developing Obesity Drugs – The Motley Fool
- How I'm Grabbing 20% Dividend Yields – The Motley Fool
- Are These Dividends Too Good to Be True? – The Motley Fool
- This Baby Is a Nice Addition – The Motley Fool
- Now Is the Time to Buy Risk – The Motley Fool
- 4-Star Stocks Poised to Pop: Merck – The Motley Fool
- Pfizer Dodges a Bullet – The Motley Fool
- Pfizer's Generic Growth, With a Side of Sashimi – The Motley Fool
- Why You Can't Afford to Miss These Stocks – The Motley Fool
- The Government Won't Be There for You – The Motley Fool
- Your Heart or Your Stomach? – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- VIVUS Gets a Spark – The Motley Fool
RSS Headlines
Fool UK
